Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Professional Medical Journal ; 29(10):1526-1532, 2022.
Artículo en Inglés | Academic Search Complete | ID: covidwho-2056974

RESUMEN

Objectives: To find out the impact of the COVID-19 epidemic in the prevalence of obsessive-compulsive disorder and differences in sociodemographic factors. Study Design: Descriptive study. Setting: Department of Psychiatry and Behavioral Sciences, Nishtar Hospital Multan. Period: January to March 2022. Material & Methods: The sample consisted of 50 OCD patients (Male=34, Females=16). Convenient sampling method was used to approach participants. Yale Brown Obsessive Compulsive scale was used along with Sociodemographic variables. Results were analyzed by using SPSS-21. Results: Findings of the study showed that Obsession with ideas of contamination and compulsion related to cleaning and washing rituals were more prevalent during Epidemic. It was also explored that there was significant increase in Incidence and prevalence of OCD during and after epidemic. Male population were more affected by OCD during Epidemic as compared to females. Residents of urban areas were more vulnerable for developing OCD. The incidents of developing OCD during the epidemic was higher in young population especially students. Conclusion: It is concluded that prevalence and incidents of OCD increased due to epidemic of COVID-19 Furthermore, it was further observed certain obsessions (obsession of contamination) and specific compulsions (cleaning and washing) was significantly higher than other types of OCD. [ FROM AUTHOR] Copyright of Professional Medical Journal is the property of Professional Medical Journal and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

2.
Medicine (Baltimore) ; 100(51): e28244, 2021 Dec 23.
Artículo en Inglés | MEDLINE | ID: covidwho-1593779

RESUMEN

RATIONALE: Bordetella bronchiseptica is a common cause of upper respiratory tract infections in domesticated dogs and cats and a rare zoonotic pathogen in immunocompromised humans. With increasing numbers of people acquiring pets and spending time with them in confined spaces due to COVID-19 lockdowns, it is important to be aware of adverse health consequences brought about by this interaction. We present a case of B bronchiseptica pneumonia in a patient with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and review key characteristics of an additional 30 cases of B bronchiseptica infections in 29 patients with HIV/AIDS that were identified by literature review. PATIENT CONCERNS: A 61-year-old male with HIV/AIDS who was not on antiretroviral therapy and had advanced immunosuppression with a CD4+ T-lymphocyte count of 3 cells/µL sought medical attention for multiple somatic issues including subjective fevers, shortness of breath, and intermittent chest pain. DIAGNOSIS: Computed tomography of the chest identified bilateral nodular opacities in the lower lobes with scattered areas of ground glass opacities. B bronchiseptica was identified in sputum culture by mass spectrometry followed by supplementary biochemical testing. INTERVENTIONS: Empiric broad-spectrum antibiotics were initiated and changed to levofloxacin after susceptibility testing was completed. OUTCOMES: The patient was discharged after symptomatic improvement with levofloxacin. LESSONS: Pneumonia with interstitial infiltrates in the setting of advanced CD4 lymphocyte depletion is the most common clinical syndrome caused by B bronchiseptica in patients with HIV/AIDS, and may be accompanied by sepsis. Advanced immune suppression, as well as chronic medical conditions, for example, alcoholism, diabetes, and renal failure that compromise host defenses are also commonly found in cases of B bronchiseptica infection in patients who do not have HIV infection. Reported animal contact among patients was not universal. Isolates were susceptible to aminoglycosides, carbapenems, fluoroquinolones, but typically resistant to most cephalosporins.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida , Infecciones por Bordetella , Bordetella bronchiseptica , Infecciones por VIH , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Síndrome de Inmunodeficiencia Adquirida/microbiología , Antibacterianos/uso terapéutico , Infecciones por Bordetella/complicaciones , Infecciones por Bordetella/diagnóstico , Infecciones por Bordetella/tratamiento farmacológico , Infecciones por VIH/complicaciones , Infecciones por VIH/microbiología , Humanos , Levofloxacino/uso terapéutico , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA